Clinical Policy: Critical Issues in the Evaluation and Management of Adult Patients Presenting to the Emergency Department with Seizures

Annals of Emergency Medicine

Volumn 43, Issue 5, 2004, Pages 605-625

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; DIAZEPAM; FOSPHENYTOIN SODIUM; LORAZEPAM; MIDAZOLAM; PENTOBARBITAL; PHENOBARBITAL; PHENYTOIN; PROPOFOL; VALPROIC ACID;

ATAXIA; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; ELECTROENCEPHALOGRAM; EMERGENCY WARD; EPILEPTIC STATE; HEALTH CARE POLICY; HEART ARREST; HEART ARRHYTHMIA; HUMAN; HYPOTENSION; MEDICAL LITERATURE; MYOCARDIAL DISEASE; NYSTAGMUS; PEER REVIEW; PHLEBITIS; PRIORITY JOURNAL; REVIEW; SEIZURE; SOMNOLENCE; TISSUE NECROSIS; TREMOR;

EID: 2342440114     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2004.01.017     Document Type: Review

References (95)

1. Hauser WA, Kurland LT. The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia. 1975;16:1-66.
2. Pashko S, McCord A, Sena MM. The cost of epilepsy and seizures in a cohort of Pennsylvania Medicaid patients. Medical Interface. 1993;November:79-84.
3. Huff JS, Morris DL, Kothari RU, et al. Emergency department management of patients with seizures: a multicenter study. Acad Emerg Med. 2001;8:622-628.
4. Begley CE, Annegers JF, Lairson DR, et al. Cost of epilepsy in the United States: a model based on incidence and prognosis. Epilepsia. 1994;35:1230-1243.
5. DeLorenzo RJ, Towne AR, Pellock JM, et al. Status epilepticus in children, adults, and the elderly. Epilepsia. 1992;33(Suppl 4):S15-25.
6. DeLorenzo RJ, Pellock JM, Towne AR, et al. Epidemiology of status epilepticus. J Clin Neurophysiol. 1995;12:316-325.
7. Lowenstein D, Bleck T, MacDonald R. It's time to revise the definition of status epilepticus. Epilepsia. 1999;40:120-122.
8. Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. 1998;339:792-798.
9. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for classification of epilepsies and epileptic syndromes. Epilepsia. 1985;26:268-278.
10. Fountain NB, Lothman EW. Pathophysiology of status epilepticus. J Clin Neurophysiol. 1995;12:326-342.
11. Cascino GD. Nonconvulsive status epilepticus in adults and children. Epilepsia. 1993;34(Suppl 1):S21-S28.
12. American College of Emergency Physicians. Clinical policy for the initial approach to patients presenting with a chief complaint of seizure who are not in status epilepticus. Ann Emerg Med. 1997;29:706-724.
13. Schriger DL, Cantrill SV, Greene CS. The origins, benefits, harms, and implications of emergency medicine clinical policies. Ann Emerg Med. 1993;22:597-602.
14. Ng S, Hauser W, Brust J, et al. Alcohol consumption and withdrawal in new-onset seizures. N Engl J Med. 1988;319:666-673.
15. Turnbull T, Vandenhoek T, Howes D, et al. Utility of laboratory studies in the ED patient with a new onset seizure. Ann Emerg Med. 1990;19:373-377.
16. Eisner R, Turnbull T, Howes D, et al. Efficacy of a standard seizure workup in the ED. Ann Emerg Med. 1986;15:33-39.
17. Sempere A, Villaverde F, Martinez-Menendez B, et al. First seizure in adults: a prospective study from the ED. Acta Neurol Scand. 1992;86:134-138.
18. Tardy B, Lafond P, Convers P, et al. Adult first generalized seizure: etiology, biological tests, EEG, CT scan, in an ED. Am J Emerg Med. 1995;13:1-5.
19. Powers R. Serum chemistry abnormalities in adult patients with seizures. Ann Emerg Med. 1985;14:416-420.
20. American Academy of Neurology. Practice parameter: evaluating a first nonfebrile seizure in children. Neurology. 2000;55:616-623.
21. Knight AH, Rhind EG. Epilepsy and pregnancy: a study of 153 pregnancies in 59 patients. Epilepsia. 1975;16:99-110.
22. Dhuna A, Pascual-Leone A, Lengendort F, et al. Epileptogenic properties of cocaine in humans. Neurotoxicology. 1991;12:621-626.
23. Olson KR, Kearney TE, Dyer JE, et al. Seizures associated with poisoning and drug overdose. Am J Emerg Med. 1993;11:565-568.
24. Pesola GR, Westfal RE. New onset generalized seizures in patients with AIDS presenting to an emergency department. Acad Emerg Med. 1998;5:905-911.
25. Green S, Rothrock S, Clem K, et al. Can seizures be the sole manifestation of meningitis in febrile children? Pediatrics. 1993;92:527-534.
26. Holtzman D, Kaku D, So Y. New onset seizures associated with human immunodeficiency virus infection: causation and clinical features in 100 cases. Am J Med. 1989;87:173-177.
27. Henneman PL, DeRoos F, Lewis RJ. Determining the need for admission in patients with new-onset seizures. Ann Emerg Med. 1994;24:1108-1114.
28. Earnest M, Feldman H, Marx J, et al. Intracranial lesions shown by CT scans in 259 cases of first alcohol related seizures. Neurology. 1988;38:1561-1565.
29. American College of Emergency Physicians, American Academy of Neurology, American Association of Neurological Surgeons, American Society of Neuroradiology. Practice parameter: neuroimaging in the emergency patient presenting with seizure. Ann Emerg Med. 1996;27:114-118.
30. Annegers J, Shirts S, Hauser W, et al. Risk of recurrence after an initial unprovoked seizure. Epilepsia. 1986;27:43-50.
31. Hauser W, Rich S, Annegers J, et al. Seizure recurrence after a first unprovoked seizure: an extended follow-up. Neurology. 1990;40:1163-1170.
32. Berg A, Shinnar S. The risk of seizure recurrence following a first unprovoked seizure: a quantitative review. Neurology. 1991;41:965-972.
33. FIRST Group. Randomized clinical trial on the efficacy of AEDs in reducing the risk of relapse after a first unprovoked tonic-clonic seizure. Neurology. 1993;43:478-483.
34. Krumholz A, Grufferman S, Orr S, et al. Seizure and seizure care in an ED. Epilepsia. 1989;30:175-181.
35. Carducci B, Hedges JR, Beal JC, et al. Emergency phenytoin loading by constant intravenous infusion. Ann Emerg Med. 1984;13:1027-1032.
36. Kugler AR, Knapp LE, Eldon MA. Rapid attainment of therapeutic phenytoin concentrations following administration of loading doses of fosphenytoin: a meta-analysis. Neurology. 1996;46:A176.
37. Leppik IE, Patrick BK, Cranford RE. Treatment of acute seizures and status epilepticus with intravenous phenytoin. Adv Neurol. 1983;34:447-451.
38. Leppik IE, Derivan AT, Homan RW, et al. Double-blind study of lorazepam and diazepam in status epilepticus. JAMA. 1983;249:1452-1454.
39. Browne TR, Davoudi H, Donn KH, et al. Bioavailability of ACC-9653 (Phenytoin prodrug). Epilepsia. 1989;30:S27-S32.
40. Wilder BJ, Campbell K, Ramsay RE, et al. Safety and tolerance of multiple doses of intramuscular fosphenytoin substituted for oral phenytoin in epilepsy or neurosurgery. Arch Neurol. 1996;53:764-768.
41. Uthman BM, Wilder BJ, Ramsay RE. Intramuscular use of fosphenytoin: an overview. Neurology. 1996;46:S24-S28.
42. Osborn HH, Zisfein J, Sparano R. Single-dose oral phenytoin loading. Ann Emerg Med. 1987;16:407-412.
43. Ratanakorn D, Kaojarem S, Phuapradit P, et al. Single oral loading dose of phenytoin: a pharmacokinetics study. J Neurol Sci. 1997;147:89-92.
44. Record KE, Rapp RP, Young AB, et al. Oral phenytoin loading in adults: rapid achievement of therapeutic plasma levels. Ann Neurol. 1979;5:268-270.
45. Wilder BJ, Serrano EE, Ramsey RE. Plasma diphenylhydantoin levels after loading and maintenance doses. Clin Pharmacol Ther. 1973;14:797-801.
46. Buchanan RA, Kinkel AW, Goulet JR. The metabolism of diphenylhydantoin (Dilantin) following once-daily administration. Neurology. 1972;22:126-130.
47. Gugler R, Manion CV, Azarnoff DL. Phenytoin: pharmacokinetics and bioavailability. Clin Pharmacol Ther. 1976;19:135-142.
48. Svensmark O, Schiller PJ, Buchthal F. 5-5-Diphenylhydantoin (Dilantin) blood levels after oral or intravenous dosage in man. Acta Pharmacol Toxicol. 1960;16:331-346.
49. Marchetti A, Magar R, Fisher J, et al. A pharmacoeconomic evaluation of intravenous fosphenytoin (Cerebyx) versus phenytoin (Dilantin) in hospital emergency departments. Clin Ther. 1996;18:953-968.
50. O'Brien TJ, Cascino GD, So EL, et al. Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin. Neurology. 1998;51:1034-1039.
51. Comer JB. Extravasation from intravenous phenytoin. Am J Intrav Ther Clin Nutr. 1984;11:23-29.
52. Earnest EP, Marx JA, Drury LR. Complications of IV phenytoin for acute treatment of seizures: recommendations for usage. JAMA. 1983;6:762-765.
53. Kilarski DJ, Buchanan C, Von Behren L. Soft-tissue damage associated with intravenous phenytoin. N Engl J Med. 1984;311:1186-1187.
54. Russell MA, Bousvaros G. Fatal results from diphenylhydantoin administered intravenously. JAMA. 1968;206:2118-2119.
55. York RC, Coleridge ST. Cardiopulmonary arrest following intravenous phenytoin loading. Am J Emerg Med. 1988;6:255-259.
56. Boucher BA, Feler CA, Dean JC, et al. The safety, tolerability, and pharmacokinetics of fosphenytoin after intramuscular and intravenous administration in neurosurgery patients. Pharmacotherapy. 1996;16:638-645.
57. Heneken SA, Knapp LE, Smith MF, et al. Tolerance of intravenous fosphenytoin (Cerebrex) compared with Dilantin: an overview of 3 studies (abstract). Epilepsia. 1996;37(Suppl 5):157.
58. Jamerson BD, Dukes GE, Brouwer KL, et al. Venous irritation related to intravenous administration of phenytoin versus fosphenytoin. Pharmacotherapy. 1994;14:47-52.
59. Browne TR. Intravenous phenytoin. Cheap but not necessarily a bargain. Neurology. 1998;51:942-943.
60. Hauser WA, Rich SS, Lee JR, et al. Risk of recurrent seizures after two unprovoked seizures. N Engl J Med. 1998;338:429-434.
61. Cranford RE, Leppik IE, Patrick B, et al. Intravenous phenytoin: clinical and pharmacokinetic aspects. Neurology. 1978;28:874-880.
62. Jagoda A, Riggio S. Refractory status epilepticus in adults. Ann Emerg Med. 1993;22:1337-1348.
63. Working Group on Status Epilepticus. Treatment of convulsive status epilepticus: recommendations of the Epilepsy Foundation of America's working group on status epilepticus. JAMA. 1993;270:854-859.
64. Lowenstein Q, Alldredge B. Status epilepticus. New Engl J Med. 1998;338:970-976.
65. Shaner DM, McCurdy SA, Herring MO, et al. Treatment of status epilepticus: a prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin. Neurology. 1988;38:202-207.
66. Runge JW, Sloan EP, Turnbull TL, et al. Intravenous fosphenytoin loading for emergent seizure control. Ann Emerg Med. 1995;25:139.
67. Osorio I, Reed RC. Treatment of refractory generalized tonic-clonic status epilepticus with pentobarbital anesthesia after high-dose phenytoin. Epilepsia. 1989;30:464-471.
68. Painter MJ, Scher MS, Stein AD, et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med. 1999;341:485-489.
69. Giroud M, Gres D, Escousse A, et al. Use of injectable valproic acid in status epilepticus. Drug Investigation. 1993;5:154-159.
70. Cempistol J, Fernandez A, Ortega J. Status epilepticus in children. Experience with intravenous valproate. Update of treatment guidelines. Rev Neurol. 1999;29:359-365.
71. Hovinga CA, Chicella MF, Rose DF, et al. Use of intravenous valproate in three pediatric patients with nonconvulsive or convulsive status epilepticus. Ann Pharmacother. 1999;33:579-584.
72. Limdi NA, Faught E. The safety of rapid valproic acid infusion. Epilepsia. 2000;41:1342-1345.
73. Sinha S, Naritoku DK. Intravenous valproate is well tolerated in unstable patients with status epilepticus. Neurology. 2000;55:722-724.
74. Borgeat A, Wilder-Smith OH, Jallon P, et al. Propofol in the management of refractory status epilepticus: a case report. Intensive Care Med. 1994;20:148-149.
75. Kuisma M, Roine RO. Propofol in prehospital treatment of convulsive status epilepticus. Epilepsia. 1995;36:1241-1243.
76. Pitt-Miller PL, Elcock BJ, Maharaj M. The management of status epilepticus with a continuous propofol infusion. Anesth Analg. 1994;78:1193-1194.
77. Stecker MM, Kramer TH, Raps EC, et al. Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings. Epilepsia. 1998;39:18-26.
78. Prasad A, Worrall RR, Bertram EH, et al. Propofol and midazolam in the treatment of refractory status epilepticus. Epilepsia. 2001;42:380-386.
79. Singhi S, Murthy A, Singhi P, et al. Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus. J Child Neurol. 2002;17:106-110.
80. Claassen J, Hirsch LJ, Emerson RG, et al. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia. 2002;43:146-153.
81. Claassen J, Hirsch LJ, Emerson RG, et al. Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus. Neurology. 2001;57:1036-1042.
82. Krishnamurthy KB, Drislane FW. Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus. Epilepsia. 1996;37:863-867.
83. Privitera MD, Strawsburg RH. Electroencephalographic monitoring in the emergency department. Emerg Med Clin North Am. 1994;12:1089-1100.
84. Quigg M, Shneker B, Domer P. Current practice in administration and clinical criteria of emergent EEG. J Clin Neurophysiol. 2001;18:162-164.
85. Kaplan PW. Nonconvulsive status epilepticus in the emergency room. Epilepsia. 1996;37:643-650.
86. Guberman A, Cantu-Reyna G, Stuss D, et al. Nonconvulsive generalized status epilepticus: clinical features, neuropsychological testing, and long-term follow-up. Neurology. 1986;36:1284-1291.
87. Bauer G, Aichner F, Mayr U. Nonconvulsive status epilepticus following generalized tonic-clonic seizures. Eur Neurol. 1982;21:411-419.
88. Fagan KJ, Lee SI. Prolonged confusion following convulsions due to generalized nonconvulsive status epilepticus. Neurology. 1990;40:1689-1694.
89. DeLorenzo RJ, Waterhouse EJ, Towne AR, et al. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia. 1998;39:833-840.
90. Bleck TP. Management approaches to prolonged seizures and status epilepticus. Epilepsia. 1999;40(Suppl 1):S59-S63.
91. Aminoff MJ. Do nonconvulsive seizures damage the brain?-No. Arch Neurol. 1998;55:119-120.
92. Young GB, Jordan KG. Do nonconvulsive seizures damage the brain?-Yes. Arch Neurol. 1998;55:117-119.
93. Towne AR, Waterhouse EJ, Boggs JG, et al. Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology. 2000;54:340-345.
94. Lowenstein DH, Aminoff MJ. Clinical and EEG features of status epilepticus in comatose patients. Neurology. 1992;42:100-104.
95. Young GB, Jordan KG, Doig GS. An assessment of nonconvulsive seizures in the intensive care unit using continuous EEG monitoring: an investigation of variables associated with mortality. Neurology. 1996;47:83-89.